Nicolet Bankshares Inc. increased its stake in Danaher Corp. (NYSE:DHR) by 1.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,814 shares of the company’s stock after buying an additional 66 shares during the period. Nicolet Bankshares Inc.’s holdings in Danaher Corp. were worth $587,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. American Century Companies Inc. bought a new position in shares of Danaher Corp. during the second quarter valued at approximately $88,276,000. Bank of Montreal Can bought a new position in shares of Danaher Corp. during the second quarter valued at approximately $39,886,000. UBS Asset Management Americas Inc. raised its position in shares of Danaher Corp. by 11.6% in the first quarter. UBS Asset Management Americas Inc. now owns 4,068,557 shares of the company’s stock valued at $385,943,000 after buying an additional 421,790 shares in the last quarter. Investec Asset Management LTD raised its position in shares of Danaher Corp. by 35.0% in the first quarter. Investec Asset Management LTD now owns 1,321,145 shares of the company’s stock valued at $125,324,000 after buying an additional 342,676 shares in the last quarter. Finally, Locust Wood Capital Advisers LLC bought a new position in shares of Danaher Corp. during the second quarter valued at approximately $30,903,000. Hedge funds and other institutional investors own 75.73% of the company’s stock.
Danaher Corp. (NYSE:DHR) traded up 0.75% during mid-day trading on Tuesday, hitting $76.43. 1,630,365 shares of the stock traded hands. Danaher Corp. has a 1-year low of $61.60 and a 1-year high of $82.64. The firm has a market cap of $52.78 billion, a price-to-earnings ratio of 15.20 and a beta of 1.13. The stock has a 50-day moving average of $77.85 and a 200 day moving average of $76.92.
Danaher Corp. (NYSE:DHR) last posted its quarterly earnings results on Monday, July 25th. The company reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.03. The firm had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.76 billion. Danaher Corp. had a net margin of 15.88% and a return on equity of 13.40%. The firm’s quarterly revenue was up 16.6% on a year-over-year basis. During the same period in the prior year, the company posted $1.08 earnings per share. On average, equities analysts expect that Danaher Corp. will post $3.56 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, September 30th will be issued a $0.125 dividend. The ex-dividend date is Wednesday, September 28th. This represents a $0.50 annualized dividend and a yield of 0.65%. Danaher Corp.’s dividend payout ratio is presently 9.94%.
DHR has been the topic of a number of research reports. Zacks Investment Research lowered shares of Danaher Corp. from a “buy” rating to a “hold” rating in a report on Thursday, September 29th. Goldman Sachs Group Inc. initiated coverage on shares of Danaher Corp. in a report on Tuesday, July 5th. They set a “neutral” rating and a $74.00 target price on the stock. Morgan Stanley reiterated a “buy” rating and set a $86.00 target price on shares of Danaher Corp. in a report on Wednesday, August 31st. JPMorgan Chase & Co. reiterated a “buy” rating and set a $90.00 target price on shares of Danaher Corp. in a report on Thursday, October 6th. Finally, Barclays PLC reiterated an “overweight” rating and set a $86.00 target price (down from $105.00) on shares of Danaher Corp. in a report on Monday, July 11th. Eight research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $92.87.
In other Danaher Corp. news, insider Thomas Patrick Joyce, Jr. sold 45,897 shares of the business’s stock in a transaction on Monday, August 1st. The shares were sold at an average price of $81.44, for a total transaction of $3,737,851.68. Following the completion of the sale, the insider now owns 179,054 shares in the company, valued at $14,582,157.76. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO Daniel L. Comas sold 96,446 shares of the business’s stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of $80.88, for a total transaction of $7,800,552.48. Following the sale, the chief financial officer now owns 215,716 shares of the company’s stock, valued at approximately $17,447,110.08. The disclosure for this sale can be found here. 12.60% of the stock is currently owned by corporate insiders.
About Danaher Corp.
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corp. (NYSE:DHR).
Receive News & Ratings for Danaher Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corp. and related companies with MarketBeat.com's FREE daily email newsletter.